<?xml version="1.0" encoding="UTF-8"?>
<paload id="" version="">
	<toplevel>
		<?oxy_comment_start author="paulnguyen" timestamp="20141111T135015-0800" comment="C: Need to add TB test to all diagnosises once Labs/Assessments is completed."?>
		<?oxy_comment_start author="paulnguyen" timestamp="20141111T150737-0800" comment="C: Go through indications and update with DXIDs, drug groups, and other aspects to match Simponi." mid="1"?>
		<routedMedId><?oxy_comment_end?><?oxy_comment_end mid="1"?>153035</routedMedId>
		<routedMedName>Stelara subcutaneous</routedMedName>
		<routedGenericName>ustekinumab subcutaneous</routedGenericName>
		<etcIds>
			<etc_id>6200</etc_id>
		</etcIds>
		<medIds>
			<medId>560326</medId>
			<medId>560327</medId>
		</medIds>
	</toplevel>
	<diagnoses>
		<diagnosis>
			<fqn>Psoriatic Arthritis-Moderate to severe</fqn>
			<age>
				<ageRangeType>ge</ageRangeType>
				<ageRangeMin>18</ageRangeMin>
				<ageRangeMax/>
				<ageRangeUnit>y</ageRangeUnit>
				<ageDesc/>
			</age>
			<gender>not specified</gender>
			<icd9>12.L40.5</icd9>
			<symbolic>Stelara-PsoriaticArthritis</symbolic>
			<rating>labeledDx</rating>
			<genotype>
				<name/>
			</genotype>
			<polymorphism>
				<name/>
			</polymorphism>
			<subtype>
				<name/>
			</subtype>
			<severity>
				<name>Moderate to severe</name>
				<code/>
				<dur/>
				<durUnit>nocode</durUnit>
			</severity>
			<prescribers>
				<prescriber>
					<name>Rheumatology</name>
					<code>207RR0500X</code>
				</prescriber>
			</prescribers>
			<comorbidities>
				<comorbidity>
					<name>Infection</name>
					<code/>
					<severity_name>Serious</severity_name>
					<severity_code/>
					<subtype/>
					<inclusion_exclusion>exclusion</inclusion_exclusion>
					<dur/>
					<durUnit>nocode</durUnit>
				</comorbidity>
			</comorbidities>
			<concurrenttherapy>
			</concurrenttherapy>
			<triedtherapy>
				<criteriaSet>
					<patientHxType>
						<typeName>all</typeName>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name/>
								<codeValues/>
								<selectedListName/>
								<selectedListClassCode/>
							</treatmentLine>
						</treatment>
					</patientHxType>
					<preferredTherapy>
						<numRequired>allorder</numRequired>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name>methotrexate sodium oral</name>
								<codeValues>02.20909</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
								<durModifier>nocode</durModifier>
								<dur/>
								<durUnit>nocode</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name>lefluonmide oral</name>
								<codeValues>02.16551</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
								<durModifier>nocode</durModifier>
								<dur/>
								<durUnit>nocode</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name>sulfasalazine oral</name>
								<codeValues>02.63166</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
								<durModifier>nocode</durModifier>
								<dur/>
								<durUnit>nocode</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name>sulfasalazine EC oral</name>
								<codeValues>02.22470</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
								<durModifier>ge</durModifier>
								<dur>3</dur>
								<durUnit>m</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<mustBeIneligible>false</mustBeIneligible>
							<documentationRequired>false</documentationRequired>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.16772|02.144657|02.154223|02.150396|02.154650|02.16554|02.152287|02.144769|02.64713</codeValues>
								<selectedListName>Tumor Necrosis Factor (TNF) Inhibitors</selectedListName>
								<selectedListClassCode>16.13</selectedListClassCode>
								<durModifier>nocode</durModifier>
								<dur/>
								<durUnit>nocode</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.165957|02.165956</codeValues>
								<selectedListName>DMARD - Phosphodiesterase-4 (PDE4) Inhibitors</selectedListName>
								<selectedListClassCode>09.6436</selectedListClassCode>
								<durModifier>ge</durModifier>
								<dur>3</dur>
								<durUnit>m</durUnit>
								<timeFrame>ever</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<mustBeIneligible>false</mustBeIneligible>
							<documentationRequired>false</documentationRequired>
						</treatment>
					</preferredTherapy>
				</criteriaSet>
			</triedtherapy>
			<triedTherapyExclusion>
				<criteriaSet>
					<?oxy_comment_start author="paulnguyen" timestamp="20141124T154403-0800" comment="C: These should go into the contraindications section (or other appropriate section) when it is ready."?>
					<excludedTherapy>
						<?oxy_comment_end?>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.164880|02.164878|02.164879|02.15402|02.94519|02.154546|02.166545|02.150450|02.94107|02.150652|02.95020|02.9755|02.11314|02.150614|02.144377</codeValues>
								<selectedListName>Live Vaccines</selectedListName>
								<selectedListClassCode>09.6421</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.144769|02.64713|02.154650|02.154223|02.150396|02.164798|02.152287|02.16554</codeValues>
								<selectedListName>Tumor Necrosis Factor (TNF) Inhibitors</selectedListName>
								<selectedListClassCode>16.13</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.22175</codeValues>
								<selectedListName>DMARD - Interleukin-1 Receptor Antagonist (IL-1Ra)</selectedListName>
								<selectedListClassCode>09.4541</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.153521|02.165329</codeValues>
								<selectedListName>DMARD - Interleukin-6 (IL-6) Receptor Inhibitors, Monoclonal Antibody</selectedListName>
								<selectedListClassCode>09.6210</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.94819|02.156713</codeValues>
								<selectedListName>DMARD - Antinflammatory, Select. costimulation modulator,T-cell Inhib.</selectedListName>
								<selectedListClassCode>09.5913</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.5206</codeValues>
								<selectedListName>DMARD - B Cell Targeted Agents</selectedListName>
								<selectedListClassCode>09.6488</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.162865</codeValues>
								<selectedListName>DMARD - Janus Kinase (JAK) Inhibitors</selectedListName>
								<selectedListClassCode>09.6387</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.152794</codeValues>
								<selectedListName>Anti-inflammatory - Interleukin-1 beta Blockers</selectedListName>
								<selectedListClassCode>09.6212</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.165957|02.165956</codeValues>
								<selectedListName>DMARD - Phosphodiesterase-4 (PDE4) Inhibitors</selectedListName>
								<selectedListClassCode>09.6436</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
					</excludedTherapy>
				</criteriaSet>
			</triedTherapyExclusion>
			<dosing>
				<text>45 mg inititally and at week 4, then 45 mg once every 12 weeks.</text>
				<text>Members with concurrent moderate-to-severe plaque psoriasis weighing > 100 kg (220 lbs): 90 mg inititally and at week 4, then 90 mg once every 12 weeks.</text>
			</dosing>
			<instructions>
				<instruction/>
			</instructions>
			<qlimits>
				<qlimit>
					<medId>03.560326</medId>
					<initPerDayDesc>Not specified</initPerDayDesc>
					<initPerIntervalDesc>2 syringes for the first 4 weeks, then 1 syringe every 12 weeks</initPerIntervalDesc>
					<renewPerDayDesc>Not specified</renewPerDayDesc>
					<renewPerIntervalDesc>1 syringe every 12 weeks</renewPerIntervalDesc>
				</qlimit>
				<qlimit>
					<medId>03.560327</medId>
					<initPerDayDesc>Not specified</initPerDayDesc>
					<initPerIntervalDesc>2 syringes for the first 4 weeks, then 1 syringe every 12 weeks</initPerIntervalDesc>
					<renewPerDayDesc>Not specified</renewPerDayDesc>
					<renewPerIntervalDesc>1 syringe every 12 weeks</renewPerIntervalDesc>
				</qlimit>
			</qlimits>
			<durations>
				<initialDur>
					<dur>1</dur>
					<durUnit>y</durUnit>
				</initialDur>
				<renewalDur>
					<dur>1</dur>
					<durUnit>y</durUnit>
				</renewalDur>
				<overallMax>
					<dur>Not specified</dur>
					<durUnit>nocode</durUnit>
				</overallMax>
			</durations>
			<references>
				<reference>Stelara [package insert]. Horsham, PA: Janssen Biotech, Inc; 2012</reference>
				<reference>Gottlieb A, Korman NJ, Gordon KB, et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2.  Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.  J Am Acad Dermatol.  2009; 58: 851-64.</reference>
			</references>
			<precautions>
				<precaution>
					<text/>
					<severity/>
				</precaution>
			</precautions>
		</diagnosis>
		<diagnosis>
			<fqn>Moderate to Severe Plaque Psoriasis</fqn>
			<age>
				<ageRangeType>ge</ageRangeType>
				<ageRangeMin>18</ageRangeMin>
				<ageRangeMax/>
				<ageRangeUnit>y</ageRangeUnit>
				<ageDesc/>
			</age>
			<gender>not specified</gender>
			<icd9>22.13956</icd9>
			<symbolic>Humira-PlaquePsoriasis</symbolic>
			<rating>labeledDx</rating>
			<genotype>
				<name/>
			</genotype>
			<polymorphism>
				<name/>
			</polymorphism>
			<subtype>
				<name/>
			</subtype>
			<severity>
				<name/>
				<code/>
				<dur/>
				<durUnit>nocode</durUnit>
			</severity>
			<prescribers>
				<prescriber>
					<name>Dermatology</name>
					<code>207N00000X</code>
				</prescriber>
			</prescribers>
			<comorbidities>
				<comorbidity>
					<name>Infection</name>
					<code/>
					<severity_name>Serious</severity_name>
					<severity_code/>
					<subtype/>
					<inclusion_exclusion>exclusion</inclusion_exclusion>
					<dur/>
					<durUnit>nocode</durUnit>
				</comorbidity>
			</comorbidities>
			<concurrenttherapy>
			</concurrenttherapy>
			<triedtherapy>
				<criteriaSet>
					<patientHxType>
						<typeName>nocode</typeName>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name/>
								<codeValues/>
								<selectedListName/>
								<selectedListClassCode/>
							</treatmentLine>
						</treatment>
					</patientHxType>
					<preferredTherapy>
						<numRequired>allorder</numRequired>
						<treatment>
							<treatmentLine>
								<?oxy_comment_start author="paulnguyen" timestamp="20141204T145509-0800" comment="C: No concurrent phototherapy with Stelara."?>
								<option><?oxy_comment_end?>WITH</option>
								<interventionType>drug</interventionType>
								<name>UV Phototherapy</name>
								<codeValues>24.96900|24.96910|24.96912|24.96913|24.96920|24.96921|24.96922</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
								<durModifier>nocode</durModifier>
								<dur/>
								<durUnit>nocode</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.5571|02.5645|02.20252|02.20909|02.7910|02.7396|02.978|02.4897|02.3392|02.1506|02.95232|02.151802|02.4403|02.76167|02.8758|02.4079|02.4272|02.6804|02.96|02.89355|02.3751|02.8786|02.5900|02.500|02.8791|02.10402|02.5901|02.6620|02.5904|02.5985|02.1456</codeValues>
								<selectedListName>Antipsoriatic Agents</selectedListName>
								<selectedListClassCode>16.15</selectedListClassCode>
								<durModifier>ge</durModifier>
								<dur>3</dur>
								<durUnit>m</durUnit>
								<timeFrame>ever</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<mustBeIneligible>false</mustBeIneligible>
							<documentationRequired>false</documentationRequired>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.16772|02.144657|02.16554|02.144769|02.64713</codeValues>
								<selectedListName>Tumor Necrosis Factor (TNF) Inhibitors</selectedListName>
								<selectedListClassCode>16.13</selectedListClassCode>
								<durModifier>nocode</durModifier>
								<dur/>
								<durUnit>nocode</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<mustBeIneligible>false</mustBeIneligible>
							<documentationRequired>false</documentationRequired>
						</treatment>
					</preferredTherapy>
				</criteriaSet>
			</triedtherapy>
			<triedTherapyExclusion>
				<criteriaSet>
					<?oxy_comment_start author="paulnguyen" timestamp="20141124T154403-0800" comment="C: These should go into the contraindications section (or other appropriate section) when it is ready."?>
					<excludedTherapy>
						<?oxy_comment_end?>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.164880|02.164878|02.164879|02.15402|02.94519|02.154546|02.166545|02.150450|02.94107|02.150652|02.95020|02.9755|02.11314|02.150614|02.144377</codeValues>
								<selectedListName>Live Vaccines</selectedListName>
								<selectedListClassCode>09.6421</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.144769|02.64713|02.154650|02.154223|02.150396|02.164798|02.152287|02.16554</codeValues>
								<selectedListName>Tumor Necrosis Factor (TNF) Inhibitors</selectedListName>
								<selectedListClassCode>16.13</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.22175</codeValues>
								<selectedListName>DMARD - Interleukin-1 Receptor Antagonist (IL-1Ra)</selectedListName>
								<selectedListClassCode>09.4541</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.153521|02.165329</codeValues>
								<selectedListName>DMARD - Interleukin-6 (IL-6) Receptor Inhibitors, Monoclonal Antibody</selectedListName>
								<selectedListClassCode>09.6210</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.94819|02.156713</codeValues>
								<selectedListName>DMARD - Antinflammatory, Select. costimulation modulator,T-cell Inhib.</selectedListName>
								<selectedListClassCode>09.5913</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.5206</codeValues>
								<selectedListName>DMARD - B Cell Targeted Agents</selectedListName>
								<selectedListClassCode>09.6488</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.162865</codeValues>
								<selectedListName>DMARD - Janus Kinase (JAK) Inhibitors</selectedListName>
								<selectedListClassCode>09.6387</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.152794</codeValues>
								<selectedListName>Anti-inflammatory - Interleukin-1 beta Blockers</selectedListName>
								<selectedListClassCode>09.6212</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.165957|02.165956</codeValues>
								<selectedListName>DMARD - Phosphodiesterase-4 (PDE4) Inhibitors</selectedListName>
								<selectedListClassCode>09.6436</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
					</excludedTherapy>
				</criteriaSet>
			</triedTherapyExclusion>
			<dosing>
				<text>Members weighing ≤ 100 kg (220 lbs): 45 mg inititally and at week 4, then 45 mg once every 12 weeks.</text>
				<text>Members with concurrent moderate-to-severe plaque psoriasis weighing > 100 kg (220 lbs): 90 mg inititally and at week 4, then 90 mg once every 12 weeks.</text>
			</dosing>
			<instructions>
				<instruction/>
			</instructions>
			<qlimits>
				<qlimit>
					<medId>03.560326</medId>
					<initPerDayDesc>Not specified</initPerDayDesc>
					<initPerIntervalDesc>2 syringes for the first 4 weeks, then 1 syringe every 12 weeks</initPerIntervalDesc>
					<renewPerDayDesc>Not specified</renewPerDayDesc>
					<renewPerIntervalDesc>1 syringe every 12 weeks</renewPerIntervalDesc>
				</qlimit>
				<qlimit>
					<medId>03.560327</medId>
					<initPerDayDesc>Not specified</initPerDayDesc>
					<initPerIntervalDesc>2 syringes for the first 4 weeks, then 1 syringe every 12 weeks</initPerIntervalDesc>
					<renewPerDayDesc>Not specified</renewPerDayDesc>
					<renewPerIntervalDesc>1 syringe every 12 weeks</renewPerIntervalDesc>
				</qlimit>
			</qlimits>
			<durations>
				<initialDur>
					<dur>1</dur>
					<durUnit>y</durUnit>
				</initialDur>
				<renewalDur>
					<dur>1</dur>
					<durUnit>y</durUnit>
				</renewalDur>
				<overallMax>
					<dur>Not specified</dur>
					<durUnit>nocode</durUnit>
				</overallMax>
			</durations>
			<references>
				<reference>Stelara [package insert]. Horsham, PA: Janssen Biotech, Inc; 2012</reference>
				<reference>Hsu S, Papp KA, Lebwohl MG, et al.  Consensus Guidelines for the Management of Plaque Psoriasis.  Arch Dermatol.  2012; 148: 95-102.  DOI 10.1001/archdermatol.2011.1410</reference>
				<reference>Voorhees AV, Feldman SR, Koo JYM, et al.  The Psoriasis and Psoriatic Arthritis Pocket Guide: Treatment algorithms and management options.  National Psoriasis Foundation.  http://www.psoriasis.org/document.doc?id=354.  Published 2009.  Accessed September 4, 2014.</reference>
				<reference>Mrowietz U, Kragballe K, Reich K, et al.  Definition of treatment goals for moderate to severe psoriasis: a European consensus.  Arch Dermatol Res.  2011; 303: 1–10. DOI 10.1007/s00403-010-1080-1</reference>
			</references>
			<precautions>
				<precaution>
					<text/>
					<severity/>
				</precaution>
			</precautions>
		</diagnosis>
		<diagnosis>
			<fqn>Crohn's Disease-Moderately to severely active</fqn>
			<age>
				<ageRangeType>gt</ageRangeType>
				<ageRangeMin>18</ageRangeMin>
				<ageRangeMax/>
				<ageRangeUnit>y</ageRangeUnit>
				<ageDesc/>
			</age>
			<gender>not specified</gender>
			<icd9>12.K50</icd9>
			<symbolic>Humira-CrohnsDisease</symbolic>
			<rating>recommendedDx</rating>
			<genotype>
				<name/>
			</genotype>
			<polymorphism>
				<name/>
			</polymorphism>
			<subtype>
				<name/>
			</subtype>
			<severity>
				<name>Moderately to severely active</name>
				<code/>
				<dur/>
				<durUnit>nocode</durUnit>
			</severity>
			<prescribers>
				<prescriber>
					<name>Gastroenterology</name>
					<code>207RG0100X</code>
				</prescriber>
			</prescribers>
			<comorbidities>
				<comorbidity>
					<name>Infection</name>
					<code/>
					<severity_name>Serious</severity_name>
					<severity_code/>
					<subtype/>
					<inclusion_exclusion>exclusion</inclusion_exclusion>
					<dur/>
					<durUnit>nocode</durUnit>
				</comorbidity>
			</comorbidities>
			<concurrenttherapy>
			</concurrenttherapy>
			<triedtherapy>
				<criteriaSet>
					<patientHxType>
						<typeName>nocode</typeName>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name/>
								<codeValues/>
								<selectedListName/>
								<selectedListClassCode/>
							</treatmentLine>
						</treatment>
					</patientHxType>
					<preferredTherapy>
						<numRequired>allorder</numRequired>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.9|02.565|02.1027|02.3398|02.4454|02.5714|02.5720|02.6007|02.6125|02.6135|02.6160|02.6307|02.6469|02.6470|02.6730|02.6731|02.6751|02.6829|02.8456|02.8641|02.8951|02.8952|02.9275|02.11321|02.13557|02.13558|02.14590|02.16235|02.18160|02.18427|02.20260|02.22007|02.22008|02.144840|02.144972|02.147015|02.150393|02.151444|02.152249|02.152303|02.153539|02.153540|02.154003|02.156314|02.159920|02.162098|02.162206|02.13557</codeValues>
								<selectedListName>Crohns Disease - glucocorticoids</selectedListName>
								<selectedListClassCode>16.06</selectedListClassCode>
								<durModifier>nocode</durModifier>
								<dur/>
								<durUnit>nocode</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.3332|02.9006|02.147055|02.151692|02.152452|02.163434|02.6260|02.6309|02.11925|02.22470|02.63166|02.11410|02.14039</codeValues>
								<selectedListName>Crohns Disease - Aminosalicylates and Related Agents</selectedListName>
								<selectedListClassCode>16.07</selectedListClassCode>
								<durModifier>nocode</durModifier>
								<dur/>
								<durUnit>nocode</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.11928|02.64887|02.13771|02.13983</codeValues>
								<selectedListName>Immunosuppressive - Purine Analogs</selectedListName>
								<selectedListClassCode>09.1251</selectedListClassCode>
								<durModifier>nocode</durModifier>
								<dur/>
								<durUnit>nocode</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.5903|02.1370|02.166385</codeValues>
								<selectedListName>Antineoplastic - Antimetabolite - Purine Analogs</selectedListName>
								<selectedListClassCode>09.2848</selectedListClassCode>
								<durModifier>ge</durModifier>
								<dur>1</dur>
								<durUnit>m</durUnit>
								<timeFrame>ever</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<mustBeIneligible>false</mustBeIneligible>
							<documentationRequired>false</documentationRequired>
						</treatment>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.154223|02.150396|02.154650|02.16554</codeValues>
								<selectedListName>Tumor Necrosis Factor (TNF) Inhibitors</selectedListName>
								<selectedListClassCode>16.13</selectedListClassCode>
								<durModifier>nocode</durModifier>
								<dur/>
								<durUnit>nocode</durUnit>
								<timeFrame>nocode</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.166319</codeValues>
								<selectedListName>Inflammatory Bowel Agent - Integrin Receptor Antagonist, MC Antibody</selectedListName>
								<selectedListClassCode>09.6471</selectedListClassCode>
								<durModifier>ge</durModifier>
								<dur>1</dur>
								<durUnit>m</durUnit>
								<timeFrame>ever</timeFrame>
								<numRequired>any</numRequired>
							</treatmentLine>
							<mustBeIneligible>false</mustBeIneligible>
							<documentationRequired>false</documentationRequired>
						</treatment>
					</preferredTherapy>
				</criteriaSet>
			</triedtherapy>
			<triedTherapyExclusion>
				<criteriaSet>
					<excludedTherapy>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.144769|02.64713|02.154650|02.154223|02.150396|02.164798|02.152287|02.16554</codeValues>
								<selectedListName>Tumor Necrosis Factor (TNF) Inhibitors</selectedListName>
								<selectedListClassCode>16.13</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.22175</codeValues>
								<selectedListName>DMARD - Interleukin-1 Receptor Antagonist (IL-1Ra)</selectedListName>
								<selectedListClassCode>09.4541</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.153521|02.165329</codeValues>
								<selectedListName>DMARD - Interleukin-6 (IL-6) Receptor Inhibitors, Monoclonal Antibody</selectedListName>
								<selectedListClassCode>09.6210</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.94819|02.156713</codeValues>
								<selectedListName>DMARD - Antinflammatory, Select. costimulation modulator,T-cell Inhib.</selectedListName>
								<selectedListClassCode>09.5913</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.5206</codeValues>
								<selectedListName>DMARD - B Cell Targeted Agents</selectedListName>
								<selectedListClassCode>09.6488</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.162865</codeValues>
								<selectedListName>DMARD - Janus Kinase (JAK) Inhibitors</selectedListName>
								<selectedListClassCode>09.6387</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.164880|02.164878|02.164879|02.15402|02.94519|02.154546|02.166545|02.150450|02.94107|02.150652|02.95020|02.9755|02.11314|02.150614|02.144377</codeValues>
								<selectedListName>Live Vaccines</selectedListName>
								<selectedListClassCode>09.6421</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.152794</codeValues>
								<selectedListName>Anti-inflammatory - Interleukin-1 beta Blockers</selectedListName>
								<selectedListClassCode>09.6212</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.153035</codeValues>
								<selectedListName>Antipsoriatic Agents - MC Antibody, Human Interleukin 12/23 Inhibitors</selectedListName>
								<selectedListClassCode>09.6200</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>group</interventionType>
								<name/>
								<codeValues>02.165957|02.165956</codeValues>
								<selectedListName>DMARD - Phosphodiesterase-4 (PDE4) Inhibitors</selectedListName>
								<selectedListClassCode>09.6436</selectedListClassCode>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
					</excludedTherapy>
				</criteriaSet>
			</triedTherapyExclusion>
			<dosing>
				<text>Initial dose (Day 1): 160 mg (four 40 mg injections in one day or two 40 mg injections per day for two consecutive days).</text>
				<text>Second dose two weeks later (Day 15): 80 mg</text>
				<text>Two weeks later (Day 29): Begin a maintenance dose of 40 mg every other week.</text>
				<text>Note: Some patients may require a maintenance dose of 40 mg every week</text>
			</dosing>
			<instructions>
				<instruction/>
			</instructions>
			<qlimits>
				<qlimit>
					<medId>03.550079</medId>
					<initPerDayDesc>Not specified</initPerDayDesc>
					<initPerIntervalDesc>1 starter pack for the first 28 days only</initPerIntervalDesc>
					<renewPerDayDesc>Not specified</renewPerDayDesc>
					<renewPerIntervalDesc>None allowed</renewPerIntervalDesc>
				</qlimit>
				<qlimit>
					<medId>03.545909</medId>
					<initPerDayDesc>Not specified</initPerDayDesc>
					<initPerIntervalDesc>6 pens per 28 days for the first 4 weeks</initPerIntervalDesc>
					<renewPerDayDesc>Not specified</renewPerDayDesc>
					<renewPerIntervalDesc>2 pens per 28 days</renewPerIntervalDesc>
				</qlimit>
				<qlimit>
					<medId>03.448215</medId>
					<initPerDayDesc>Not specified</initPerDayDesc>
					<initPerIntervalDesc>6 kits per 28 days for the first 4 weeks</initPerIntervalDesc>
					<renewPerDayDesc>Not specified</renewPerDayDesc>
					<renewPerIntervalDesc>2 kits per 28 days</renewPerIntervalDesc>
				</qlimit>
			</qlimits>
			<durations>
				<initialDur>
					<dur>1</dur>
					<durUnit>y</durUnit>
				</initialDur>
				<renewalDur>
					<dur>1</dur>
					<durUnit>y</durUnit>
				</renewalDur>
				<overallMax>
					<dur>Not specified</dur>
					<durUnit>nocode</durUnit>
				</overallMax>
			</durations>
			<references>
				<reference>Humira [package insert]. North Chicago, IL: AbbVie Inc; 2014</reference>
				<reference>Lichtenstein GR, Hanauer SB, Sandborn WJ.  Management of Crohn's Disease in Adutls.  Am J Gastroenterol.  2009; 104: 465-83.  doi: 10.1038/ajg.2008.168</reference>
				<reference>Sandborn WJ, Feagan BG, Lichtenstein GR.  Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.  Aliment Pharmacol Ther.  2007; 26: 987-1003.</reference>
				<reference>Thomson ABR, Gupta M, Freeman HJ.  Use of the tumor necrosis factor-blockers for Crohn's disease.  World J Gastroenterol.  2012; 18: 4823-54.  doi:10.3748/wjg.v18.i35.4823</reference>
			</references>
			<precautions>
				<precaution>
					<text/>
					<severity/>
				</precaution>
			</precautions>
		</diagnosis>
	</diagnoses>
	<precautions>
		<geriatric>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</geriatric>
		<pregnancy>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</pregnancy>
		<pediatric>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</pediatric>
		<lactation>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</lactation>
		<allergy>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</allergy>
		<sideEffect>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</sideEffect>
		<drugDisease>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</drugDisease>
	</precautions>
	<lists>
		<listDef>
			<name>Tumor Necrosis Factor (TNF) Inhibitors</name>
			<codeValue>16.13</codeValue>
			<listType>adhoc</listType>
			<listItem>
				<name>Enbrel SureClick subcutaneous</name>
				<codeValue>02.144657</codeValue>
			</listItem>
			<listItem>
				<name>Enbrel subcutaneous</name>
				<codeValue>02.16772</codeValue>
			</listItem>
			<listItem>
				<name>Cimzia Powder for Reconstitution subcutaneous</name>
				<codeValue>02.154650</codeValue>
			</listItem>
			<listItem>
				<name>Cimzia Starter Kit subcutaneous</name>
				<codeValue>02.154223</codeValue>
			</listItem>
			<listItem>
				<name>Cimzia subcutaneous</name>
				<codeValue>02.150396</codeValue>
			</listItem>
			<listItem>
				<name>Simponi ARIA intravenous</name>
				<codeValue>02.164798</codeValue>
			</listItem>
			<listItem>
				<name>Simponi subcutaneous</name>
				<codeValue>02.152287</codeValue>
			</listItem>
			<listItem>
				<name>Remicade intravenous</name>
				<codeValue>02.16554</codeValue>
			</listItem>
			<listItem>
				<name>Humira Pen subcutaneous</name>
				<codeValue>02.144769</codeValue>
			</listItem>
			<listItem>
				<name>Humira subcutaneous</name>
				<codeValue>02.64713</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>DMARD - Interleukin-1 Receptor Antagonist (IL-1Ra)</name>
			<codeValue>09.4541</codeValue>
			<listType>class</listType>
			<listItem>
				<name>Kineret subcutaneous</name>
				<codeValue>02.22175</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>DMARD - Interleukin-6 (IL-6) Receptor Inhibitors, Monoclonal Antibody</name>
			<codeValue>09.6210</codeValue>
			<listType>class</listType>
			<listItem>
				<name>Actemra intravenous</name>
				<codeValue>02.153521</codeValue>
			</listItem>
			<listItem>
				<name>Actemra subcutaneous</name>
				<codeValue>02.165329</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>DMARD - Antinflammatory, Select. costimulation modulator,T-cell Inhib.</name>
			<codeValue>09.5913</codeValue>
			<listType>class</listType>
			<listItem>
				<name>Orencia (with maltose) intravenous</name>
				<codeValue>02.94819</codeValue>
			</listItem>
			<listItem>
				<name>Orencia subcutaneous</name>
				<codeValue>02.156713</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>DMARD - B Cell Targeted Agents</name>
			<codeValue>09.6488</codeValue>
			<listType>class</listType>
			<listItem>
				<name>Rituxan intravenous</name>
				<codeValue>02.5206</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>DMARD - Janus Kinase (JAK) Inhibitors</name>
			<codeValue>09.6387</codeValue>
			<listType>class</listType>
			<listItem>
				<name>Xeljanz oral</name>
				<codeValue>02.162865</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>Live Vaccines</name>
			<codeValue>09.6421</codeValue>
			<listType>class</listType>
			<listItem>
				<name>adenovirus vaccine live type-4 and 7 oral</name>
				<codeValue>02.164880</codeValue>
			</listItem>
			<listItem>
				<name>adenovirus vaccine live type-4 oral</name>
				<codeValue>02.164878</codeValue>
			</listItem>
			<listItem>
				<name>adenovirus vaccine live type-7 oral</name>
				<codeValue>02.164879</codeValue>
			</listItem>
			<listItem>
				<name>Theracys intravesical</name>
				<codeValue>02.15402</codeValue>
			</listItem>
			<listItem>
				<name>Tice BCG intravesical</name>
				<codeValue>02.94519</codeValue>
			</listItem>
			<listItem>
				<name>BCG vaccine, live (PF) percutaneous</name>
				<codeValue>02.154546</codeValue>
			</listItem>
			<listItem>
				<name>Flumist Quad 2014-2015 nasal</name>
				<codeValue>02.166545</codeValue>
			</listItem>
			<listItem>
				<name>M-M-R II (PF) subcutaneous</name>
				<codeValue>02.150450</codeValue>
			</listItem>
			<listItem>
				<name>ProQuad (PF) subcutaneous</name>
				<codeValue>02.94107</codeValue>
			</listItem>
			<listItem>
				<name>Rotarix oral</name>
				<codeValue>02.150652</codeValue>
			</listItem>
			<listItem>
				<name>RotaTeq Vaccine oral</name>
				<codeValue>02.95020</codeValue>
			</listItem>
			<listItem>
				<name>Vivotif Berna Vaccine oral</name>
				<codeValue>02.9755</codeValue>
			</listItem>
			<listItem>
				<name>Varivax (PF) subcutaneous</name>
				<codeValue>02.11314</codeValue>
			</listItem>
			<listItem>
				<name>YF-Vax (PF) subcutaneous</name>
				<codeValue>02.150614</codeValue>
			</listItem>
			<listItem>
				<name>ZOSTAVAX  subcutaneous</name>
				<codeValue>02.144377</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>Anti-inflammatory - Interleukin-1 beta Blockers</name>
			<codeValue>09.6212</codeValue>
			<listType>class</listType>
			<listItem>
				<name>Ilaris (PF) subcutaneous</name>
				<codeValue>02.152794</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>Antipsoriatic Agents - MC Antibody, Human Interleukin 12/23 Inhibitors</name>
			<codeValue>09.6200</codeValue>
			<listType>class</listType>
			<listItem>
				<name>Stelara subcutaneous</name>
				<codeValue>02.153035</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>DMARD - Phosphodiesterase-4 (PDE4) Inhibitors</name>
			<codeValue>09.6436</codeValue>
			<listType>class</listType>
			<listItem>
				<name>Otezla Starter oral</name>
				<codeValue>02.165957</codeValue>
			</listItem>
			<listItem>
				<name>Otezla oral</name>
				<codeValue>02.165956</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>glucocorticoids, oral or IV</name>
			<codeValue>09.2750</codeValue>
			<listType>class</listType>
			<listItem>
				<name>A-Hydrocort injection</name>
				<codeValue>02.8951</codeValue>
			</listItem>
			<listItem>
				<name>A-Methapred injection</name>
				<codeValue>02.8952</codeValue>
			</listItem>
			<listItem>
				<name>Aristospan Intra-Articular injection</name>
				<codeValue>02.6576</codeValue>
			</listItem>
			<listItem>
				<name>Aristospan Intralesional injection</name>
				<codeValue>02.5589</codeValue>
			</listItem>
			<listItem>
				<name>Asmalpred oral</name>
				<codeValue>02.156971</codeValue>
			</listItem>
			<listItem>
				<name>Asmalpred Plus oral</name>
				<codeValue>02.154500</codeValue>
			</listItem>
			<listItem>
				<name>Celestone oral</name>
				<codeValue>02.8456</codeValue>
			</listItem>
			<listItem>
				<name>Cortef oral</name>
				<codeValue>02.6730</codeValue>
			</listItem>
			<listItem>
				<name>cortisone oral</name>
				<codeValue>02.8641</codeValue>
			</listItem>
			<listItem>
				<name>Depo-Medrol injection</name>
				<codeValue>02.6160</codeValue>
			</listItem>
			<listItem>
				<name>dexamethasone in 0.9 % sodium chloride intravenous</name>
				<codeValue>02.159920</codeValue>
			</listItem>
			<listItem>
				<name>Dexamethasone Intensol oral</name>
				<codeValue>02.16235</codeValue>
			</listItem>
			<listItem>
				<name>dexamethasone oral</name>
				<codeValue>02.1027</codeValue>
			</listItem>
			<listItem>
				<name>dexamethasone sodium phosphate (PF) injection</name>
				<codeValue>02.147015</codeValue>
			</listItem>
			<listItem>
				<name>dexamethasone sodium phosphate injection</name>
				<codeValue>02.6751</codeValue>
			</listItem>
			<listItem>
				<name>DexPak 10 day oral</name>
				<codeValue>02.144972</codeValue>
			</listItem>
			<listItem>
				<name>DexPak 13 Day oral</name>
				<codeValue>02.18160</codeValue>
			</listItem>
			<listItem>
				<name>DexPak 6 Day oral</name>
				<codeValue>02.162098</codeValue>
			</listItem>
			<listItem>
				<name>Flo-Pred oral</name>
				<codeValue>02.156314</codeValue>
			</listItem>
			<listItem>
				<name>hydrocortisone oral</name>
				<codeValue>02.6731</codeValue>
			</listItem>
			<listItem>
				<name>hydrocortisone sodium succinate injection</name>
				<codeValue>02.6829</codeValue>
			</listItem>
			<listItem>
				<name>Kenalog injection</name>
				<codeValue>02.9275</codeValue>
			</listItem>
			<listItem>
				<name>Medrol (Pak) oral</name>
				<codeValue>02.11321</codeValue>
			</listItem>
			<listItem>
				<name>Medrol oral</name>
				<codeValue>02.6469</codeValue>
			</listItem>
			<listItem>
				<name>methylprednisolone acetate injection</name>
				<codeValue>02.4454</codeValue>
			</listItem>
			<listItem>
				<name>methylprednisolone oral</name>
				<codeValue>02.6470</codeValue>
			</listItem>
			<listItem>
				<name>methylprednisolone sodium succ injection</name>
				<codeValue>02.3398</codeValue>
			</listItem>
			<listItem>
				<name>methylprednisolone sodium succ intravenous</name>
				<codeValue>02.18427</codeValue>
			</listItem>
			<listItem>
				<name>Millipred DP oral</name>
				<codeValue>02.152249</codeValue>
			</listItem>
			<listItem>
				<name>Millipred oral</name>
				<codeValue>02.150393</codeValue>
			</listItem>
			<listItem>
				<name>Orapred ODT oral</name>
				<codeValue>02.144840</codeValue>
			</listItem>
			<listItem>
				<name>Orapred oral</name>
				<codeValue>02.20260</codeValue>
			</listItem>
			<listItem>
				<name>Pediapred oral</name>
				<codeValue>02.13558</codeValue>
			</listItem>
			<listItem>
				<name>prednisolone oral</name>
				<codeValue>02.6307</codeValue>
			</listItem>
			<listItem>
				<name>prednisolone sodium phosphate oral</name>
				<codeValue>02.13557</codeValue>
			</listItem>
			<listItem>
				<name>Prednisone Intensol oral</name>
				<codeValue>02.14590</codeValue>
			</listItem>
			<listItem>
				<name>prednisone oral</name>
				<codeValue>02.6007</codeValue>
			</listItem>
			<listItem>
				<name>Prelone oral</name>
				<codeValue>02.565</codeValue>
			</listItem>
			<listItem>
				<name>Rayos oral</name>
				<codeValue>02.162206</codeValue>
			</listItem>
			<listItem>
				<name>Solu-Cortef (PF) injection</name>
				<codeValue>02.154003</codeValue>
			</listItem>
			<listItem>
				<name>Solu-Cortef injection</name>
				<codeValue>02.6125</codeValue>
			</listItem>
			<listItem>
				<name>Solu-Medrol (PF) injection</name>
				<codeValue>02.153539</codeValue>
			</listItem>
			<listItem>
				<name>Solu-Medrol (PF) intravenous</name>
				<codeValue>02.153540</codeValue>
			</listItem>
			<listItem>
				<name>Solu-Medrol injection</name>
				<codeValue>02.6135</codeValue>
			</listItem>
			<listItem>
				<name>Solu-Medrol intravenous</name>
				<codeValue>02.152303</codeValue>
			</listItem>
			<listItem>
				<name>triamcinolone acetonide injection</name>
				<codeValue>02.9</codeValue>
			</listItem>
			<listItem>
				<name>Veripred 20 oral</name>
				<codeValue>02.151444</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>Inflammatory Bowel Agent - Glucocorticoids</name>
			<codeValue>09.927</codeValue>
			<listType>class</listType>
			<listItem>
				<name>Entocort EC oral</name>
				<codeValue>02.22007</codeValue>
			</listItem>
			<listItem>
				<name>budesonide oral</name>
				<codeValue>02.22008</codeValue>
			</listItem>
			<listItem>
				<name>Cortifoam rectal</name>
				<codeValue>02.4997</codeValue>
			</listItem>
			<listItem>
				<name>hydrocortisone rectal</name>
				<codeValue>02.6241</codeValue>
			</listItem>
			<listItem>
				<name>Colocort rectal</name>
				<codeValue>02.18021</codeValue>
			</listItem>
			<listItem>
				<name>Cortenema rectal</name>
				<codeValue>02.7131</codeValue>
			</listItem>
			<listItem>
				<name>Uceris oral</name>
				<codeValue>02.163364</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>Inflammatory Bowel Agent - Aminosalicylates and Related Agents</name>
			<codeValue>09.3013</codeValue>
			<listType>class</listType>
			<listItem>
				<name>balsalazide oral</name>
				<codeValue>02.20258</codeValue>
			</listItem>
			<listItem>
				<name>Colazal oral</name>
				<codeValue>02.20259</codeValue>
			</listItem>
			<listItem>
				<name>Giazo oral</name>
				<codeValue>02.163103</codeValue>
			</listItem>
			<listItem>
				<name>Asacol oral</name>
				<codeValue>02.9006</codeValue>
			</listItem>
			<listItem>
				<name>Pentasa oral</name>
				<codeValue>02.3332</codeValue>
			</listItem>
			<listItem>
				<name>Delzicol oral</name>
				<codeValue>02.163434</codeValue>
			</listItem>
			<listItem>
				<name>Asacol HD oral</name>
				<codeValue>02.152452</codeValue>
			</listItem>
			<listItem>
				<name>Apriso oral</name>
				<codeValue>02.151692</codeValue>
			</listItem>
			<listItem>
				<name>Lialda oral</name>
				<codeValue>02.147055</codeValue>
			</listItem>
			<listItem>
				<name>Canasa rectal</name>
				<codeValue>02.20905</codeValue>
			</listItem>
			<listItem>
				<name>Rowasa rectal</name>
				<codeValue>02.9791</codeValue>
			</listItem>
			<listItem>
				<name>mesalamine rectal</name>
				<codeValue>02.9866</codeValue>
			</listItem>
			<listItem>
				<name>sfRowasa rectal</name>
				<codeValue>02.151704</codeValue>
			</listItem>
			<listItem>
				<name>Rowasa rectal</name>
				<codeValue>02.9791</codeValue>
			</listItem>
			<listItem>
				<name>mesalamine with cleansing wipes rectal</name>
				<codeValue>02.150711</codeValue>
			</listItem>
			<listItem>
				<name>Dipentum oral</name>
				<codeValue>02.14039</codeValue>
			</listItem>
			<listItem>
				<name>sulfasalazine oral</name>
				<codeValue>02.6260</codeValue>
			</listItem>
			<listItem>
				<name>Azulfidine EN-tabs oral</name>
				<codeValue>02.6309</codeValue>
			</listItem>
			<listItem>
				<name>Azulfidine oral</name>
				<codeValue>02.11925</codeValue>
			</listItem>
			<listItem>
				<name>Sulfazine EC oral</name>
				<codeValue>02.22470</codeValue>
			</listItem>
			<listItem>
				<name>Sulfazine oral</name>
				<codeValue>02.63166</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>Crohns Disease - glucocorticoids</name>
			<codeValue>16.06</codeValue>
			<listType>adhoc</listType>
			
			<listItem>
				<name>triamcinolone acetonide injection</name>
				<codeValue>02.9</codeValue>
			</listItem>
			<listItem>
				<name>Prelone oral</name>
				<codeValue>02.565</codeValue>
			</listItem>
			<listItem>
				<name>dexamethasone oral</name>
				<codeValue>02.1027</codeValue>
			</listItem>
			<listItem>
				<name>methylprednisolone sodium succ injection</name>
				<codeValue>02.3398</codeValue>
			</listItem>
			<listItem>
				<name>methylprednisolone acetate injection</name>
				<codeValue>02.4454</codeValue>
			</listItem>
			<listItem>
				<name>betamethasone acetate and sodium phosphate injection</name>
				<codeValue>02.5714</codeValue>
			</listItem>
			<listItem>
				<name>Celestone Soluspan injection</name>
				<codeValue>02.5720</codeValue>
			</listItem>
			<listItem>
				<name>prednisone oral</name>
				<codeValue>02.6007</codeValue>
			</listItem>
			<listItem>
				<name>Solu-Cortef injection</name>
				<codeValue>02.6125</codeValue>
			</listItem>
			<listItem>
				<name>Solu-Medrol injection</name>
				<codeValue>02.6135</codeValue>
			</listItem>
			<listItem>
				<name>Depo-Medrol injection</name>
				<codeValue>02.6160</codeValue>
			</listItem>
			<listItem>
				<name>prednisolone oral</name>
				<codeValue>02.6307</codeValue>
			</listItem>
			<listItem>
				<name>Medrol oral</name>
				<codeValue>02.6469</codeValue>
			</listItem>
			<listItem>
				<name>methylprednisolone oral</name>
				<codeValue>02.6470</codeValue>
			</listItem>
			<listItem>
				<name>Cortef oral</name>
				<codeValue>02.6730</codeValue>
			</listItem>
			<listItem>
				<name>hydrocortisone oral</name>
				<codeValue>02.6731</codeValue>
			</listItem>
			<listItem>
				<name>dexamethasone sodium phosphate injection</name>
				<codeValue>02.6751</codeValue>
			</listItem>
			<listItem>
				<name>hydrocortisone sodium succinate injection</name>
				<codeValue>02.6829</codeValue>
			</listItem>
			<listItem>
				<name>Celestone oral</name>
				<codeValue>02.8456</codeValue>
			</listItem>
			<listItem>
				<name>cortisone oral</name>
				<codeValue>02.8641</codeValue>
			</listItem>
			<listItem>
				<name>A-Hydrocort injection</name>
				<codeValue>02.8951</codeValue>
			</listItem>
			<listItem>
				<name>A-Methapred injection</name>
				<codeValue>02.8952</codeValue>
			</listItem>
			<listItem>
				<name>Kenalog injection</name>
				<codeValue>02.9275</codeValue>
			</listItem>
			<listItem>
				<name>Medrol (Pak) oral</name>
				<codeValue>02.11321</codeValue>
			</listItem>
			<listItem>
				<name>prednisolone sodium phosphate oral</name>
				<codeValue>02.13557</codeValue>
			</listItem>
			<listItem>
				<name>Pediapred oral</name>
				<codeValue>02.13558</codeValue>
			</listItem>
			<listItem>
				<name>Prednisone Intensol oral</name>
				<codeValue>02.14590</codeValue>
			</listItem>
			<listItem>
				<name>Dexamethasone Intensol oral</name>
				<codeValue>02.16235</codeValue>
			</listItem>
			<listItem>
				<name>DexPak 13 Day oral</name>
				<codeValue>02.18160</codeValue>
			</listItem>
			<listItem>
				<name>methylprednisolone sodium succ intravenous</name>
				<codeValue>02.18427</codeValue>
			</listItem>
			<listItem>
				<name>Orapred oral</name>
				<codeValue>02.20260</codeValue>
			</listItem>
			<listItem>
				<name>Entocort EC oral</name>
				<codeValue>02.22007</codeValue>
			</listItem>
			<listItem>
				<name>budesonide oral</name>
				<codeValue>02.22008</codeValue>
			</listItem>
			<listItem>
				<name>Orapred ODT oral</name>
				<codeValue>02.144840</codeValue>
			</listItem>
			<listItem>
				<name>DexPak 10 day oral</name>
				<codeValue>02.144972</codeValue>
			</listItem>
			<listItem>
				<name>dexamethasone sodium phosphate (PF) injection</name>
				<codeValue>02.147015</codeValue>
			</listItem>
			<listItem>
				<name>Millipred oral</name>
				<codeValue>02.150393</codeValue>
			</listItem>
			<listItem>
				<name>Veripred 20 oral</name>
				<codeValue>02.151444</codeValue>
			</listItem>
			<listItem>
				<name>Millipred DP oral</name>
				<codeValue>02.152249</codeValue>
			</listItem>
			<listItem>
				<name>Solu-Medrol intravenous</name>
				<codeValue>02.152303</codeValue>
			</listItem>
			<listItem>
				<name>Solu-Medrol (PF) injection</name>
				<codeValue>02.153539</codeValue>
			</listItem>
			<listItem>
				<name>Solu-Medrol (PF) intravenous</name>
				<codeValue>02.153540</codeValue>
			</listItem>
			<listItem>
				<name>Solu-Cortef (PF) injection</name>
				<codeValue>02.154003</codeValue>
			</listItem>
			<listItem>
				<name>Flo-Pred oral</name>
				<codeValue>02.156314</codeValue>
			</listItem>
			<listItem>
				<name>dexamethasone in 0.9 % sodium chloride intravenous</name>
				<codeValue>02.159920</codeValue>
			</listItem>
			<listItem>
				<name>DexPak 6 Day oral</name>
				<codeValue>02.162098</codeValue>
			</listItem>
			<listItem>
				<name>Rayos oral</name>
				<codeValue>02.162206</codeValue>
			</listItem>
			<listItem>
				<name>prednisolone sodium phosphate oral</name>
				<codeValue>02.13557</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>Crohns Disease - Aminosalicylates and Related Agents</name>
			<codeValue>16.07</codeValue>
			<listType>adhoc</listType>
			
			<listItem>
				<name>Pentasa oral</name>
				<codeValue>02.3332</codeValue>
			</listItem>
			<listItem>
				<name>Asacol oral</name>
				<codeValue>02.9006</codeValue>
			</listItem>
			<listItem>
				<name>Lialda oral</name>
				<codeValue>02.147055</codeValue>
			</listItem>
			<listItem>
				<name>Apriso oral</name>
				<codeValue>02.151692</codeValue>
			</listItem>
			<listItem>
				<name>Asacol HD oral</name>
				<codeValue>02.152452</codeValue>
			</listItem>
			<listItem>
				<name>Delzicol oral</name>
				<codeValue>02.163434</codeValue>
			</listItem>
			<listItem>
				<name>sulfasalazine oral</name>
				<codeValue>02.6260</codeValue>
			</listItem>
			<listItem>
				<name>Azulfidine EN-tabs oral</name>
				<codeValue>02.6309</codeValue>
			</listItem>
			<listItem>
				<name>Azulfidine oral</name>
				<codeValue>02.11925</codeValue>
			</listItem>
			<listItem>
				<name>Sulfazine EC oral</name>
				<codeValue>02.22470</codeValue>
			</listItem>
			<listItem>
				<name>Sulfazine oral</name>
				<codeValue>02.63166</codeValue>
			</listItem>
			<listItem>
				<name>Paser oral</name>
				<codeValue>02.11410</codeValue>
			</listItem>
			<listItem>
				<name>Dipentum oral</name>
				<codeValue>02.14039</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>Immunosuppressive - Purine Analogs</name>
			<codeValue>09.1251</codeValue>
			<listType>class</listType>
			<listItem>
				<name>Azathioprine injection</name>
				<codeValue>02.11928</codeValue>
			</listItem>
			<listItem>
				<name>Azasan oral</name>
				<codeValue>02.64887</codeValue>
			</listItem>
			<listItem>
				<name>azathioprine oral</name>
				<codeValue>02.13771</codeValue>
			</listItem>
			<listItem>
				<name>Imuran oral</name>
				<codeValue>02.13983</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>Antineoplastic - Antimetabolite - Purine Analogs</name>
			<codeValue>09.2848</codeValue>
			<listType>class</listType>
			<listItem>
				<name>mercaptopurine oral</name>
				<codeValue>02.5903</codeValue>
			</listItem>
			<listItem>
				<name>Purinethol oral</name>
				<codeValue>02.1370</codeValue>
			</listItem>
			<listItem>
				<name>Purixan oral</name>
				<codeValue>02.166385</codeValue>
			</listItem>
		</listDef>
		<listDef>
			<name>Antipsoriatic Agents</name>
			<codeValue>16.15</codeValue>
			<listType>adhoc</listType>
			<listItem>
				<name>acitretin oral</name>
				<codeValue>02.5571</codeValue>
			</listItem>
			<listItem>
				<name>cyclosporine oral</name>
				<codeValue>02.5645</codeValue>
			</listItem>
			<listItem>
				<name>cyclosporine modified oral</name>
				<codeValue>02.20252</codeValue>
			</listItem>
			<listItem>
				<name>methotrexate sodium oral</name>
				<codeValue>02.20909</codeValue>
			</listItem>
			<listItem>	<name>alclometasone topical</name>	<codeValue>02.7910</codeValue>	</listItem>
			<listItem>	<name>amcinonide topical</name>	<codeValue>02.7396</codeValue>	</listItem>
			<listItem>	<name>betamethasone dipropionate topical</name>	<codeValue>02.978</codeValue>	</listItem>
			<listItem>	<name>betamethasone valerate topical</name>	<codeValue>02.4897</codeValue>	</listItem>
			<listItem>	<name>betamethasone, augmented topical</name>	<codeValue>02.3392</codeValue>	</listItem>
			<listItem>	<name>calcipotriene topical</name>	<codeValue>02.1506</codeValue>	</listItem>
			<listItem>	<name>calcipotriene-betamethasone topical</name>	<codeValue>02.95232</codeValue>	</listItem>
			<listItem>	<name>calcitriol topical</name>	<codeValue>02.151802</codeValue>	</listItem>
			<listItem>	<name>clobetasol topical</name>	<codeValue>02.4403</codeValue>	</listItem>
			<listItem>	<name>clobetasol-emollient topical</name>	<codeValue>02.76167</codeValue>	</listItem>
			<listItem>	<name>clocortolone pivalate topical</name>	<codeValue>02.8758</codeValue>	</listItem>
			<listItem>	<name>desonide topical</name>	<codeValue>02.4079</codeValue>	</listItem>
			<listItem>	<name>desoximetasone topical</name>	<codeValue>02.4272</codeValue>	</listItem>
			<listItem>	<name>diflorasone topical</name>	<codeValue>02.6804</codeValue>	</listItem>
			<listItem>	<name>fluocinonide topical</name>	<codeValue>02.96</codeValue>	</listItem>
			<listItem>	<name>fluocinonide-emollient topical</name>	<codeValue>02.89355</codeValue>	</listItem>
			<listItem>	<name>flurandrenolide topical</name>	<codeValue>02.3751</codeValue>	</listItem>
			<listItem>	<name>fluticasone topical</name>	<codeValue>02.8786</codeValue>	</listItem>
			<listItem>	<name>halobetasol propionate topical</name>	<codeValue>02.5900</codeValue>	</listItem>
			<listItem>	<name>hydrocortisone acetate topical</name>	<codeValue>02.500</codeValue>	</listItem>
			<listItem>	<name>hydrocortisone butyrate topical</name>	<codeValue>02.8791</codeValue>	</listItem>
			<listItem>	<name>hydrocortisone topical</name>	<codeValue>02.10402</codeValue>	</listItem>
			<listItem>	<name>hydrocortisone valerate topical</name>	<codeValue>02.5901</codeValue>	</listItem>
			<listItem>	<name>hydrocortisone-urea topical</name>	<codeValue>02.6620</codeValue>	</listItem>
			<listItem>	<name>mometasone topical</name>	<codeValue>02.5904</codeValue>	</listItem>
			<listItem>	<name>prednicarbate topical</name>	<codeValue>02.5985</codeValue>	</listItem>
			<listItem>	<name>triamcinolone acetonide topical</name>	<codeValue>02.1456</codeValue>	</listItem>
			
		</listDef>
		<listDef>
			<name>Inflammatory Bowel Agent - Integrin Receptor Antagonist, MC Antibody</name>
			<codeValue>09.6471</codeValue>
			<listType>class</listType>
			<listItem>
				<name>Entyvio intravenous</name>
				<codeValue>02.166319</codeValue>
			</listItem>
		</listDef>
	</lists>
</paload>
